ArticleScientific reports2025
Nepenthes pitcher fluid for the green synthesis of silver nanoparticles with biofilm inhibition, anticancer and antioxidant properties.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Harnessing Tolypothrix sp. A-8 for biogenic synthesis of silver oxide nanoparticles (AgONPs) for multifunctional biomedical applications.Discover nano · 2026Article
- Eco-friendly biosynthesis of silver nanoparticles using marine-derived Fusarium exquisite: optimization, characterization, and evaluation of antimicrobial, antioxidant, and cytotoxic activities.World journal of microbiology & biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is the first report of silver nanoparticles (AgNPs) synthesis utilizing the pitcher secretion from an insectivorous plant, specifically Nepenthes ventrata, through a microwave assisted green synthesis approach. The successful formation of AgNPs was validated through a comprehensive set of analyses, including UV-Vis spectroscopy, Fourier-transform infrared spectroscopy, transmission electron microscopy, DLS analysis and Zeta potential measurements. In addition gas chromatography-high-resolution mass spectrometry and liquid chromatography-high-resolution mass spectrometry analyses were conducted to examine the components present in the pitcher secretion. These analyses aimed to identify the capping and stabilizing agents in the secretion that facilitate the synthesis and stability of AgNPs. The synthesized AgNPs significantly inhibited biofilm formation by Pseudomonas aeruginosa PAO1, as demonstrated by Crystal Violet staining and fluorescence microscopy. Additionally, these AgNPs showed promising antioxidant properties through a DPPH radical scavenging assay. Furthermore, the anticancer properties of the AgNPs were analyzed using an MTT assay, which measures cell metabolic activity as an indicator of cell viability, proliferation, and cytotoxicity. Collectively, these findings suggest that the biosynthesized AgNPs possess multifaceted biological applications, showcasing their utility as both antimicrobial and antioxidative agents, and highlighting their potential in medical and environmental applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.